Attached files

file filename
8-K - 8-K - NUTRI SYSTEM INC /DE/ntri-8k_20181030.htm

 

Exhibit 99.1

Contact:

John Mills, Partner

ICR, Inc.

646-277-1254

ir@nutrisystem.com

John.Mills@Icrinc.com

 

NUTRISYSTEM ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS

Diluted Income Per Share Increased 10% to $0.54 for Third Quarter 2018

Company Expects to Achieve Full Year 2018 Revenue, Diluted Income Per Share and Adjusted EBITDA Guidance Ranges

Board Authorizes New $75 Million Stock Repurchase Program

 

Fort Washington, PA—October 30, 2018—Nutrisystem, Inc. (Nasdaq: NTRI), a leading provider of health and wellness and weight management products and services including Nutrisystem® and South Beach Diet® brands, today reported financial results for the quarter and nine months ended September 30, 2018.  

 

Dawn Zier, President and Chief Executive Officer, stated, “I’m pleased we delivered year-over-year growth in the third quarter and adjusted EBITDA and earnings per share are aligned with expectations. South Beach growth remains strong and, most importantly, we see a clear path to return the Nutrisystem brand to growth in 2019.” 

 

Ms. Zier added, “During the second half of the year we’re focused on positioning our company for a return to meaningful growth in 2019. We’re doing this in three primary ways and have arrived at the proof points that give us confidence that our plans will deliver that. First, our innovation efforts are centered around personalized nutrition and flexibility to better engage with consumers both at the start and throughout their journey to optimal health. Second, our new creative for 2019 supports our evolving brand promise, resonates well with consumers, and we’re seeing early evidence that our creative approach will drive response and engagement. And finally, we’re actively refining our media deployment strategy to expand reach, grow digital, and increase marketing efficiency. We’re excited about our future.”

 

The following are key financial highlights for the period. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.

 

Third Quarter 2018 Compared to Third Quarter 2017

 

Revenue was $159.3 million compared to $158.1 million.

 

Gross margin was 52.3% compared to 54.2%.

 

Net income was $16.0 million compared to $15.0 million.

 

Diluted income per common share was $0.54 compared to $0.49.

 

Adjusted EBITDA was $26.8 million compared to $27.7 million.

 

Company repurchased $1.3 million of common stock during the third quarter of 2018 for a total of $26.3 million during the first nine months of 2018.


 

 

The Board of Directors has declared a quarterly dividend of $0.25 per share, payable November 19, 2018 to stockholders of record as of November 9, 2018.

 

Mike Monahan, Chief Financial Officer, commented, “Our third quarter and year-to-date results demonstrate the strength of our business model as we continued to generate increased free cash flow. Our strong balance sheet has allowed us to repurchase $26.3 million of stock in the first nine months of this year, and as of September 30, 2018, we had approximately $92.6 million in cash and cash equivalents and short-term investments, and no long-term debt. The Board of Directors has authorized a new $75 million buyback program set to expire October 2020. We will continue to utilize our balance sheet to enhance the long-term value of our company.”

 

Fourth Quarter and Full Year 2018 Guidance

 

The Company’s fourth quarter and full year 2018 guidance is outlined below. In preparation of 2019, the Company has made some deliberate decisions around media deployment and media mix in the second half of the year that have had a small impact on current year revenue but position the Company more strongly for the new year. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.

 

 

Fourth quarter revenue is expected to be in the range of $129.5 to $134.5 million, net income between $17.3 and $18.9 million, diluted income per common share between $0.58 and $0.63, and adjusted EBITDA between $29.4 and $31.4 million.

 

Full year 2018 revenue is expected to be in the range of $691 to $696 million, net income between $62.2 and $63.8 million, diluted income per common share between $2.08 and $2.13, and adjusted EBITDA between $105.1 and $107.1 million.  The South Beach Diet brand is projected to be $66-$70 million in revenue in 2018.

 

Conference Call and Webcast

 

Management will host a conference call to discuss third quarter 2018 financial results today at 5:00 PM Eastern time. The conference call will include remarks from President and Chief Executive Officer, Dawn Zier, Chief Financial Officer, Mike Monahan, and Chief Marketing Officer, Keira Krausz. A webcast of the conference call will be available live on the Investor Relations section of Nutrisystem's website at www.nutrisystem.com. Interested parties unable to access the conference call via the webcast may dial 877-407-3982. A replay of the conference call will be available on the Company’s website for 30 days following the event and can be accessed at 844-512-2921 using replay pin number 13683560.

 

Non-GAAP Financial Measures  

 

Within this press release, the Company makes reference to a non-GAAP financial measure (adjusted EBITDA) which has a directly comparable GAAP financial measure (net income). EBITDA is defined as net income excluding interest, income taxes and depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding non-cash employee compensation expense and transaction costs related to stockholder cooperation agreement. The Company excludes non-cash employee compensation expense because it is a non-cash expense that is not reflective of the ongoing cash expense of the Company. The Company excludes the transaction costs as the matter was resolved and is not reflective of the ongoing operations of the Company. Adjusted EBITDA is provided so that investors have the same financial data that management uses to assess the Company’s operating results


 

with the belief that it will assist the investment community in properly assessing the ongoing performance of the Company for the periods being reported and future periods. The presentation of this additional information is not meant to be considered a substitute for measures prepared in accordance with GAAP.  

 

Forward-Looking Statements

 

Information provided and statements contained in this press release that are not purely historical, such as fourth quarter and updated full year 2018 guidance, and the Company’s financial and operational outlook, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, risks relating to cybersecurity breaches, risks that consumer spending may decline or that U.S. and global macroeconomic conditions may worsen resulting in reduced demand for the Company’s products, risks relating to changes in consumer preferences away from the Company’s food offerings including its pre-packaged foods, risks relating to the effectiveness and efficiency of the Company’s advertising campaigns and marketing expenditures, including existing brands and the launch of new brands, which may not result in increased revenue or generate sufficient levels of brand name and program awareness, risks if the Company is unable to obtain sufficient quantities, quality and variety of food products in a timely and low-cost manner from its food vendors, risks of exposure to product liability claims if the use of the Company’s products results in illness or injury, risks if the Company becomes subject to health or advertising related claims from its customers, competitors or governmental and regulatory bodies, and risks relating to increased competition from other weight management providers. For further details and a discussion of these risks and uncertainties, see the Company's periodic reports, including the annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the results of any revisions to the forward-looking statements made in this press release.

 

About Nutrisystem, Inc.

 

Nutrisystem, Inc. (Nasdaq: NTRI) is a leading provider of health and wellness and weight management products and services and has helped millions of people lose weight over the course of more than 45 years. The Company’s multi-brand approach to weight loss includes multiple plans for 2018. For more information, go to NutrisystemNews.com and Newsroom.SouthBeachDiet.com.

 

 

 

 

 

 

 



 

NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share amounts)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

REVENUE

 

$

159,255

 

 

$

158,149

 

 

$

561,496

 

 

$

565,720

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

76,010

 

 

 

72,357

 

 

 

263,032

 

 

 

259,684

 

Marketing

 

 

43,018

 

 

 

42,067

 

 

 

176,167

 

 

 

168,585

 

Selling, general and administrative

 

 

16,024

 

 

 

18,626

 

 

 

54,607

 

 

 

59,620

 

Depreciation and amortization

 

 

3,931

 

 

 

3,755

 

 

 

11,531

 

 

 

11,321

 

Total costs and expenses

 

 

138,983

 

 

 

136,805

 

 

 

505,337

 

 

 

499,210

 

Operating income

 

 

20,272

 

 

 

21,344

 

 

 

56,159

 

 

 

66,510

 

INTEREST INCOME, net

 

 

(314

)

 

 

(48

)

 

 

(512

)

 

 

(74

)

Income before income tax expense

 

 

20,586

 

 

 

21,392

 

 

 

56,671

 

 

 

66,584

 

INCOME TAX EXPENSE

 

 

4,592

 

 

 

6,365

 

 

 

11,738

 

 

 

19,638

 

Net income

 

$

15,994

 

 

$

15,027

 

 

$

44,933

 

 

$

46,946

 

BASIC INCOME PER COMMON SHARE

 

$

0.54

 

 

$

0.50

 

 

$

1.51

 

 

$

1.57

 

DILUTED INCOME PER COMMON SHARE

 

$

0.54

 

 

$

0.49

 

 

$

1.50

 

 

$

1.54

 

WEIGHTED AVERAGE SHARES OUTSTANDING:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

29,208

 

 

 

29,799

 

 

 

29,466

 

 

 

29,685

 

Diluted

 

 

29,573

 

 

 

30,299

 

 

 

29,797

 

 

 

30,164

 

DIVIDENDS DECLARED PER COMMON SHARE

 

$

0.250

 

 

$

0.175

 

 

$

0.750

 

 

$

0.525

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except par value amounts)

 

 

September 30,

 

 

December 31,

 

 

 

2018

 

 

2017

 

ASSETS

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

38,158

 

 

$

24,654

 

Short term investments

 

 

54,394

 

 

 

47,568

 

Receivables

 

 

19,125

 

 

 

17,871

 

Inventories

 

 

30,373

 

 

 

44,266

 

Prepaid income taxes

 

 

693

 

 

 

6,441

 

Prepaid expenses and other current assets

 

 

8,237

 

 

 

11,758

 

Total current assets

 

 

150,980

 

 

 

152,558

 

FIXED ASSETS, net

 

 

27,695

 

 

 

31,549

 

INTANGIBLE ASSETS, net

 

 

12,334

 

 

 

13,084

 

DEFERRED INCOME TAXES

 

 

3,177

 

 

 

3,202

 

OTHER ASSETS

 

 

1,199

 

 

 

1,150

 

Total assets

 

$

195,385

 

 

$

201,543

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Accounts payable

 

$

35,541

 

 

$

34,816

 

Accrued payroll and related benefits

 

 

2,306

 

 

 

15,229

 

Deferred revenue

 

 

9,287

 

 

 

7,991

 

Other accrued expenses and current liabilities

 

 

5,883

 

 

 

6,068

 

Total current liabilities

 

 

53,017

 

 

 

64,104

 

NON-CURRENT LIABILITIES

 

 

1,801

 

 

 

1,636

 

Total liabilities

 

 

54,818

 

 

 

65,740

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

 

 

 

Preferred stock, $.001 par value (5,000 shares authorized, no shares issued  

   and outstanding)

 

 

0

 

 

 

0

 

Common stock, $.001 par value (100,000 shares authorized; shares issued –  

   30,977 at September 30, 2018 and 30,729 at December 31, 2017)

 

 

31

 

 

 

31

 

Additional paid-in capital

 

 

78,939

 

 

 

69,245

 

Treasury stock, at cost, 1,558 shares at September 30, 2018 and 679 shares at

   December 31, 2017

 

 

(44,579

)

 

 

(16,359

)

Retained earnings

 

 

106,436

 

 

 

83,035

 

Accumulated other comprehensive loss

 

 

(260

)

 

 

(149

)

Total stockholders’ equity

 

 

140,567

 

 

 

135,803

 

Total liabilities and stockholders’ equity

 

$

195,385

 

 

$

201,543

 

 

 

 

 

 

 

 

 


 

NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net income

 

$

44,933

 

 

$

46,946

 

Adjustments to reconcile net income to net cash provided by operating   

   activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

11,531

 

 

 

11,321

 

Share–based compensation expense

 

 

7,755

 

 

 

7,899

 

Deferred income tax benefit

 

 

(323

)

 

 

(1,015

)

Other charges

 

 

41

 

 

 

26

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Receivables

 

 

(1,254

)

 

 

(1,338

)

Inventories

 

 

13,893

 

 

 

14,670

 

Prepaid expenses and other assets

 

 

3,602

 

 

 

2,945

 

Accounts payable

 

 

733

 

 

 

599

 

Accrued payroll and related benefits

 

 

(12,923

)

 

 

(373

)

Deferred revenue

 

 

2,633

 

 

 

1,891

 

Income taxes

 

 

5,794

 

 

 

(2,032

)

Other accrued expenses and liabilities

 

 

(811

)

 

 

(586

)

Net cash provided by operating activities

 

 

75,604

 

 

 

80,953

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Purchases of short term investments

 

 

(18,651

)

 

 

(30,196

)

Proceeds from the sale and maturity of short term investments

 

 

11,643

 

 

 

12,080

 

Capital additions

 

 

(6,144

)

 

 

(9,088

)

Net cash used in investing activities

 

 

(13,152

)

 

 

(27,204

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

1,939

 

 

 

4,144

 

Employee tax withholdings related to the vesting of equity awards

 

 

(1,916

)

 

 

(1,596

)

Repurchase of common shares for treasury

 

 

(26,304

)

 

 

0

 

Repurchase and retirement of common shares

 

 

0

 

 

 

(2,285

)

Payment of dividends

 

 

(22,667

)

 

 

(15,987

)

Net cash used in financing activities

 

 

(48,948

)

 

 

(15,724

)

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

 

13,504

 

 

 

38,025

 

CASH AND CASH EQUIVALENTS, beginning of period

 

 

24,654

 

 

 

9,623

 

CASH AND CASH EQUIVALENTS, end of period

 

$

38,158

 

 

$

47,648

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

NUTRISYSTEM, INC. AND SUBSIDIARIES

 

ADJUSTED EBITDA RECONCILIATION TO GAAP RESULTS

 

(Unaudited, in thousands)

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

15,994

 

 

$

15,027

 

 

$

44,933

 

 

$

46,946

 

   Interest income, net

 

(314

)

 

 

(48

)

 

 

(512

)

 

 

(74

)

   Income tax expense

 

4,592

 

 

 

6,365

 

 

 

11,738

 

 

 

19,638

 

   Depreciation and amortization

 

3,931

 

 

 

3,755

 

 

 

11,531

 

 

 

11,321

 

EBITDA

 

24,203

 

 

 

25,099

 

 

 

67,690

 

 

 

77,831

 

   Non-cash employee compensation expense

 

2,318

 

 

 

2,625

 

 

 

7,755

 

 

 

7,899

 

   Transaction costs related to stockholder

      cooperation agreement

 

273

 

 

 

0

 

 

 

273

 

 

 

0

 

Adjusted EBITDA

$

26,794

 

 

$

27,724

 

 

$

75,718

 

 

$

85,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NUTRISYSTEM, INC. AND SUBSIDIARIES

 

ADJUSTED EBITDA RECONCILIATION TO GAAP GUIDANCE

 

(Unaudited, in thousands)

 

 

Three Months Ending

December 31, 2018

 

 

Twelve Months Ending

December 31, 2018

 

 

Low

 

 

High

 

 

Low

 

 

High

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

17,287

 

 

$

18,863

 

 

$

62,220

 

 

$

63,796

 

   Interest income, net

 

(148)

 

 

 

(148)

 

 

 

(660)

 

 

 

(660)

 

   Income tax expense

 

5,002

 

 

 

5,426

 

 

 

16,740

 

 

 

17,164

 

   Depreciation and amortization

 

3,949

 

 

 

3,949

 

 

 

15,480

 

 

 

15,480

 

EBITDA

 

26,090

 

 

 

28,090

 

 

 

93,780

 

 

 

95,780

 

   Non-cash employee compensation expense

 

2,435

 

 

 

2,435

 

 

 

10,190

 

 

 

10,190

 

   Transaction costs related to stockholder

      cooperation agreement

 

857

 

 

 

857

 

 

 

1,130

 

 

 

1,130

 

Adjusted EBITDA

$

29,382

 

 

$

31,382

 

 

$

105,100

 

 

$

107,100